Trial Profile
Phase 3 double-blind placebo-controlled randomized trial of Z-100 in patients with radiation therapy for cervical cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Z 100 (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Zeria
- 31 May 2013 Primary endpoint 'Overall-survival-rate' has not been met.
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 19 Jan 2012 Planned end date changed from 1 Jun 2010 to 1 Mar 2013 as reported by University Hospital Medical Information Network - Japan.